Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-11

Clinical Trial Update: Neurocognitive Effects of Opiate Agonist Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining neurocognitive effects of opiate agonist treatment in opioid-related disorders with HIV co-occurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Opioid-Related Disorders, HIV | Phase 4 | Status: COMPLETED